Armistice Capital, Llc Kiora Pharmaceuticals Inc (KPRX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 3.35 Million shares of KPRX, which is worth approximately $12.1 Million. The most recent transaction as insider was on Jan 06, 2021, when has been sold 1,531,101 shares (Common Stock) at a price of $5.22 per share, resulting in proceeds of $7,992,347. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.35M

0% 3M change

0% 12M change

Total Value Held $12.1 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2021	BUY Open market or private purchase	$7,992,347 $5.22 p/Share	1,531,101 Added 31.39%	3,346,601 Common Stock
Feb 10 2020	BUY Open market or private purchase	$72,480 $6.04 p/Share	12,000 Added 0.66%	1,815,500 Common Stock
Feb 06 2020	BUY Open market or private purchase	$67,980 $6.18 p/Share	11,000 Added 0.61%	1,803,500 Common Stock
Sep 30 2019	BUY Open market or private purchase	$15,703 $3.14 p/Share	5,001 Added 0.28%	1,792,500 Common Stock
Sep 29 2019	BUY Open market or private purchase	$1,872,000 $3.12 p/Share	600,000 Added 25.13%	1,787,499 Common Stock
Mar 29 2019	BUY Open market or private purchase	$92,439 $0.31 p/Share	298,189 Added 1.65%	17,812,500 Common Stock
Mar 28 2019	BUY Open market or private purchase	$40,551 $0.31 p/Share	130,811 Added 0.74%	17,514,311 Common Stock
Mar 27 2019	BUY Open market or private purchase	$42,226 $0.35 p/Share	120,647 Added 0.69%	17,383,500 Common Stock
Dec 11 2018	BUY Open market or private purchase	$13,000 $0.42 p/Share	30,953 Added 0.18%	17,262,853 Common Stock
Dec 10 2018	BUY Open market or private purchase	$27,760 $0.4 p/Share	69,400 Added 0.4%	17,231,900 Common Stock
Nov 16 2018	BUY Open market or private purchase	$83,724 $0.47 p/Share	178,136 Added 1.03%	17,162,500 Common Stock
Nov 15 2018	BUY Open market or private purchase	$54,496 $0.43 p/Share	126,735 Added 0.74%	16,984,364 Common Stock
Nov 14 2018	BUY Open market or private purchase	$23,705 $0.43 p/Share	55,129 Added 0.33%	16,857,629 Common Stock
May 29 2018	BUY Open market or private purchase	$23,199 $0.57 p/Share	40,700 Added 0.24%	16,802,500 Common Stock
May 25 2018	BUY Open market or private purchase	$10,193 $0.58 p/Share	17,575 Added 0.1%	16,761,800 Common Stock
May 18 2018	BUY Open market or private purchase	$966 $0.56 p/Share	1,725 Added 0.01%	16,744,225 Common Stock
May 14 2018	BUY Open market or private purchase	$8,509 $0.54 p/Share	15,758 Added 0.09%	16,742,500 Common Stock
May 11 2018	BUY Open market or private purchase	$26,537 $0.54 p/Share	49,142 Added 0.29%	16,726,742 Common Stock
May 10 2018	BUY Open market or private purchase	$12,915 $0.54 p/Share	23,917 Added 0.14%	16,677,600 Common Stock
May 09 2018	BUY Open market or private purchase	$51,976 $0.5 p/Share	103,953 Added 0.62%	16,653,683 Common Stock
May 08 2018	BUY Open market or private purchase	$18,243 $0.49 p/Share	37,230 Added 0.22%	16,549,730 Common Stock
May 07 2018	BUY Open market or private purchase	$6,983 $0.49 p/Share	14,252 Added 0.09%	16,512,500 Common Stock
May 04 2018	BUY Open market or private purchase	$39,444 $0.46 p/Share	85,748 Added 0.52%	16,498,248 Common Stock
Apr 26 2018	BUY Open market or private purchase	$43,200 $0.54 p/Share	80,000 Added 0.49%	16,412,500 Common Stock
Apr 25 2018	BUY Open market or private purchase	$46,182 $0.54 p/Share	85,522 Added 0.52%	16,332,500 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL